Clinical Research Directory
Browse clinical research sites, groups, and studies.
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
Sponsor: Children's Hospital Medical Center, Cincinnati
Summary
There are limited data regarding the biology and treatment of relapsed/refractory hepatoblastoma (rrHBL). This project provides the infrastructure for acquisition of biological specimens, imaging, and correlative clinical data to facilitate biology studies and characterization of rrHBL. This registry will collect clinical, demographic, and pathological data, specimens (as available) and imaging from patients with rrHBL, prospectively. Cases are identified through: 1. Existing clinical and/or cancer registry databases 2. Referrals from clinicians, surgeons, or pathologists 3. Families initiating contact with Registry staff directly
Official title: Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Hepatic Tumors Research Consortium Initiative
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2022-09-07
Completion Date
2040-09-01
Last Updated
2026-03-18
Healthy Volunteers
No
Interventions
Biospecimen collection
Clinical information and biospecimens will be collected
Locations (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States